Tracking birth outcomes and birth defects after delivery
Part of Genetic & congenital, Immune system & allergy, Infections clinical trials.
This study follows pregnant people and their babies to better measure adverse outcomes and possible congenital (from birth) conditions. It may help improve how birth risks and birth defects are identified and recorded at the clinic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and getting your prenatal care (ANC) at the study site
- You can understand English or Swahili
- You can give informed consent (no disability that prevents consent)
- Your baby is born at the study site, and the birth is registered there
- For photos/videos: your baby is at least 24 weeks and has a suspected birth defect seen on outward exam
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows pregnant women and their babies to see how well HIV prevention medicines work during pregnancy. It aims to help keep both mother and baby healthy.
This study helps connect health and appointment data to better track pregnancies and improve how often women attend antenatal (prenatal) clinic visits. If you live in the study area and are currently pregnant or within six weeks after delivery, you may be eligible to participate.
This study looks at ways to test and treat newborns for HIV early to improve their long-term health. It is for mothers with HIV whose babies are less than 3 days old and who are willing to have their babies tested and followed at home.
This trial tests an experimental vaccine for babies who were exposed to HIV while in the womb but are not infected. Mothers must be living with HIV, on treatment, and deliver by C-section at the study hospital in Soweto.
This study follows pregnant women with viral infections (like HIV or hepatitis) and their babies to see how the infection and treatments affect both. It aims to improve care for mothers and children.
This trial is a pregnancy registry that collects information about birth outcomes when certain HIV medicines are taken during pregnancy. It helps detect any major birth defects so future pregnancies can be safer.
Hear when a new HIV/AIDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.